When I last reviewed the entire cannabis sector a month ago, I pointed to a big change: Not all of the stocks were moving in the same direction. My thesis was and remains the same: Investors are beginning to differentiate on both transparency as well as leverage to the big themes of recreational legalization and a more enthusiastic embracing of the medical benefits of marijuana. Again, the DOJ "hands-off" policy that gave the green light to Colorado and Washington to proceed with their implementations as well as Sanjay Gupta's reversal of his previously negative view on the medical aspects, both August events, paved the way for investors to sharpen their focus on these themes.
As I suggested then (note: here is a link to all of my previous articles on the sector), two of the better stocks to take advantage of these themes are GW Pharma (GWPH) for medical and GrowLife (OTC:PHOT) for recreational (but also medical). As you can see, these two stocks enjoyed a strong month: